Alfresa Holdings Corporation (TYO:2784)

Market Cap	363.59B
Revenue (ttm)	2.94T
Net Income (ttm)	34.41B
Shares Out	184.37M
EPS (ttm)	184.34
PE Ratio	10.70
Forward PE	12.07
Dividend	64.00 (3.25%)
Ex-Dividend Date	Mar 28, 2025

Volume	470,500
Average Volume	542,220
Open	2,078.50
Previous Close	2,085.50
Day's Range	1,994.50 - 2,086.00
52-Week Range	1,929.00 - 2,473.50
Beta	0.00
RSI	32.89
Earnings Date	Feb 10, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,517
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2023, Alfresa Holdings's revenue was 2.86 trillion, an increase of 6.02% compared to the previous year's 2.70 trillion. Earnings were 29.56 billion, an increase of 14.63%.